Nix-Mediated Apoptosis Links Myocardial Fibrosis, Cardiac Remodeling, and Hypertrophy Decompensation

Background— Pathological cardiac hypertrophy inevitably remodels, leading to functional decompensation. Although modulation of apoptosis-regulating genes occurs in cardiac hypertrophy, a causal role for programmed cardiomyocyte death in left ventricular (LV) remodeling has not been established. Methods and Results— We targeted the gene for proapoptotic Nix, which is transcriptionally upregulated in pressure overload and Gq-dependent hypertrophies, in the mouse germ line or specifically in cardiomyocytes (knockout [KO]) and conditionally overexpressed it in the heart (transgenic [TG]). Conditional forced Nix expression acted synergistically with the prohypertrophic Gq transgene to increase cardiomyocyte apoptosis (0.8±0.1% in GqTG versus 7.8±0.6% in GqTG+NixTG; P<0.001), causing lethal cardiomyopathy with LV dilation and depressed systolic function (percent fractional shortening, 39±4 versus 23±4; P=0.042). In the reciprocal experiment, germ-line Nix ablation significantly reduced cardiomyocyte apoptosis (4.8±0.2% in GqTG+Nix KO versus 8.4±0.5% in GqTG; P=0.001), which improved percent fractional shortening (43±3% versus 27±3%; P=0.017), attenuated LV remodeling, and largely prevented lethality in the Gq peripartum model of apoptotic cardiomyopathy. Cardiac-specific (Nkx2.5-Cre) Nix KO mice subjected to transverse aortic constriction developed significantly less LV dilation by echocardiography and magnetic resonance imaging, maintained concentric remodeling, and exhibited preserved LV ejection fraction (61±2% in transverse aortic constriction cardiac Nix KO versus 36±6% in transverse aortic constriction wild-type mice; P=0.003) at 9 weeks, with reduced cardiomyocyte apoptosis at day 4 (1.70±0.21% versus 2.73±0.35%; P=0.032). Conclusions— Nix-induced cardiomyocyte apoptosis is a major determinant of adverse remodeling in pathological hypertrophies, a finding that suggests therapeutic value for apoptosis inhibition to prevent cardiomyopathic decompensation.

[1]  G. Dorn,et al.  Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. , 2007, The Journal of clinical investigation.

[2]  G. Dorn.  Myocardial angiogenesis: its absence makes the growing heart founder. , 2007, Cell metabolism.

[3]  G. Dorn.  The Fuzzy Logic of Physiological Cardiac Hypertrophy , 2007, Hypertension.

[4]  G. Dorn,et al.  Unrestrained erythroblast development in Nix−/− mice reveals a mechanism for apoptotic modulation of erythropoiesis , 2007, Proceedings of the National Academy of Sciences.

[5]  I. Komuro,et al.  p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload , 2007, Nature.

[6]  G. Dorn,et al.  Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. , 2007, Physiology.

[7]  I. Shiojima,et al.  Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. , 2006, Genes & development.

[8]  G. Dorn,et al.  Cardiac-Specific Ablation of G-Protein Receptor Kinase 2 Redefines Its Roles in Heart Development and &bgr;-Adrenergic Signaling , 2006, Circulation research.

[9]  R. Dietz,et al.  Apoptosis Repressor With Caspase Recruitment Domain Is Required for Cardioprotection in Response to Biomechanical and Ischemic Stress , 2006, Circulation.

[10]  G. Dorn,et al.  Distinct Pathways Regulate Proapoptotic Nix and BNip3 in Cardiac Stress* , 2006, Journal of Biological Chemistry.

[11]  John W. Adams,et al.  Ca2+ Dysregulation Induces Mitochondrial Depolarization and Apoptosis , 2005, Journal of Biological Chemistry.

[12]  I. Shiojima,et al.  Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. , 2005, The Journal of clinical investigation.

[13]  G. Dorn.  Physiologic growth and pathologic genes in cardiac development and cardiomyopathy. , 2005, Trends in cardiovascular medicine.

[14]  P. Doevendans,et al.  Downregulation of Apoptosis-Inducing Factor in Harlequin Mutant Mice Sensitizes the Myocardium to Oxidative Stress–Related Cell Death and Pressure Overload–Induced Decompensation , 2005, Circulation research.

[15]  G. Dorn,et al.  Physiological Growth Synergizes With Pathological Genes in Experimental Cardiomyopathy , 2004, Circulation research.

[16]  Young-Jae Nam,et al.  The Mitochondrial Death Pathway and Cardiac Myocyte Apoptosis , 2004, Circulation research.

[17]  K. P. Roos,et al.  Functional Adult Myocardium in the Absence of Na+-Ca2+ Exchange: Cardiac-Specific Knockout of NCX1 , 2004, Circulation research.

[18]  G. Dorn,et al.  Inhibition of Cardiac Myocyte Apoptosis Improves Cardiac Function and Abolishes Mortality in the Peripartum Cardiomyopathy of G&agr;q Transgenic Mice , 2003, Circulation.

[19]  S. Fox,et al.  Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade , 2003, The Journal of pathology.

[20]  S. S. Zhang,et al.  Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Dorn,et al.  Phenotyping hypertrophy: eschew obfuscation. , 2003, Circulation research.

[22]  R. Kitsis,et al.  A mechanistic role for cardiac myocyte apoptosis in heart failure. , 2003, The Journal of clinical investigation.

[23]  L. Kirshenbaum,et al.  Inducible Expression of BNIP3 Provokes Mitochondrial Defects and Hypoxia-Mediated Cell Death of Ventricular Myocytes , 2002, Circulation research.

[24]  S. Vatner,et al.  The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. , 2002, The Journal of clinical investigation.

[25]  A. Marks.  Clinical implications of cardiac ryanodine receptor/calcium release channel mutations linked to sudden cardiac death. , 2002, Circulation.

[26]  G. Dorn,et al.  Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy , 2002, Nature Medicine.

[27]  S. Cherry,et al.  Cardiac Myocyte-Specific Excision of the &bgr;1 Integrin Gene Results in Myocardial Fibrosis and Cardiac Failure , 2002, Circulation research.

[28]  R. Schwartz,et al.  Embryonic expression of an Nkx2‐5/Cre gene using ROSA26 reporter mice , 2001, Genesis.

[29]  K. Chien,et al.  Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes , 2001, Nature Medicine.

[30]  J. Gruen,et al.  Peaks of linkage are localized by a BAC/PAC contig of the 6p reading disability locus. , 2001, Genomics.

[31]  A. Harris,et al.  HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. , 2001, Cancer research.

[32]  R. Weiss.  Imaging the murine cardiovascular system with magnetic resonance. , 2001, Circulation research.

[33]  John W. Adams,et al.  Cardiomyocyte Apoptosis Induced by G&agr;q Signaling Is Mediated by Permeability Transition Pore Formation and Activation of the Mitochondrial Death Pathway , 2000, Circulation research.

[34]  R. D. Gietz,et al.  The C. elegans orthologue ceBNIP3 interacts with CED-9 and CED-3 but kills through a BH3- and caspase-independent mechanism , 2000, Oncogene.

[35]  Xiao-Ming Yin,et al.  Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways , 2000, Cell Research.

[36]  R. Kerber,et al.  Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. , 2000, Circulation.

[37]  Paul A. Overbeek,et al.  TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice , 2000, Nature Medicine.

[38]  G. Condorelli,et al.  Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure. , 2000, Circulation research.

[39]  A Haase,et al.  Developmental changes of cardiac function and mass assessed with MRI in neonatal, juvenile, and adult mice. , 2000, American journal of physiology. Heart and circulatory physiology.

[40]  J. Ross,et al.  Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress , 1999, Cell.

[41]  Lianfa Shi,et al.  Nix and Nip3 Form a Subfamily of Pro-apoptotic Mitochondrial Proteins* , 1999, The Journal of Biological Chemistry.

[42]  John W. Adams,et al.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Lefkowitz,et al.  Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. , 1998, Science.

[44]  G. Dorn,et al.  Decompensation of Pressure-Overload Hypertrophy in Gαq-Overexpressing Mice , 1998 .

[45]  G. Dorn,et al.  Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .

[46]  B. A. French,et al.  Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. , 1997, The Journal of clinical investigation.

[47]  L. Gaboury,et al.  Apoptosis in pressure overload-induced heart hypertrophy in the rat. , 1996, The Journal of clinical investigation.

[48]  M. Weiner,et al.  Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. , 1995, Circulation.

[49]  D E Manyari,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[50]  J. Scheuer,et al.  Physiologic cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy in rats. , 1982, The Journal of clinical investigation.

[51]  R. Gottlieb,et al.  Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy , 2007, Cell Death and Differentiation.

[52]  D. Kass,et al.  Altered high-energy phosphate metabolism predicts contractile dysfunction and subsequent ventricular remodeling in pressure-overload hypertrophy mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[53]  A. Strasser,et al.  BH3 - only proteins: evolutionarily conserved proapoptotic Bcl - 2 family members essential for init , 2002 .

[54]  Michael D. Schneider,et al.  Still stressed out but doing fine: normalization of wall stress is superfluous to maintaining cardiac function in chronic pressure overload. , 2002, Circulation.

[55]  W. Koch,et al.  Genetic Alterations That Inhibit In Vivo Pressure-Overload Hypertrophy Prevent Cardiac Dysfunction Despite Increased Wall Stress , 2002, Circulation.

[56]  K. Chien,et al.  Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. , 2001, Nature medicine.

[57]  G. Dorn,et al.  Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice. , 1998, Circulation.

[58]  G. Dorn,et al.  Transgenic Galphaq overexpression induces cardiac contractile failure in mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[59]  G. Dorn,et al.  Genetic Causes of Cardiac Hypertrophy Divergent Transcriptional Responses to Independent , 2022 .